The Federal Trade Commission also reported the “Big ... Her company, which owns Aetna, the pharmacy benefits manager operation CVS Caremark and several doctors’ clinic chains, reported ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
In late December, President-elect Donald Trump put pharmacy benefit managers ... Warren and activist regulators at Joe Biden’s Federal Trade Commission, which dropped a report just days before ...
As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust ...
Oil and gas production in the United States is hitting record highs, easily outpacing consumption growth and fueling an export boom that in 2020 achieved the country's first trade surplus in energy ...
The Federal Trade Commission also reported the “Big 3 PBMs” also ... Her company, which owns Aetna, the pharmacy benefits manager operation CVS Caremark and several doctors’ clinic chains, reported ...
2don MSNOpinion
As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...
The Federal Trade Commission (FTC) has sued the top three pharmacy benefit ... drug prices will only benefit pharma companies, while the Pharmaceutical Care Management Association (PCMA), a ...
At least one Woodward pharmacist is celebrating an action by Oklahoma Attorney General Gentner Drummond that could turn the tide for area pharmacists, some who are struggling stay in business ...
A bundle of healthcare legislation that would introduce greater oversight of the pharmacy ... benefit pharma manufacturers with a "$10 billion profit-boosting windfall." A Federal Trade Commission ...
President Donald Trump started his second administration with a blitz of policy actions to reorient the U.S. government.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback